Immunological reactivity and bioactivity of tumour necrosis factor. 1988

C M Petersen, and B K Møller

UI MeSH Term Description Entries
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

C M Petersen, and B K Møller
January 1988, Lancet (London, England),
C M Petersen, and B K Møller
November 2005, Annals of the rheumatic diseases,
C M Petersen, and B K Møller
October 1988, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
C M Petersen, and B K Møller
April 1989, British medical bulletin,
C M Petersen, and B K Møller
April 1988, Microbiological sciences,
C M Petersen, and B K Møller
December 1990, The Ceylon medical journal,
C M Petersen, and B K Møller
April 1988, British medical journal (Clinical research ed.),
C M Petersen, and B K Møller
March 1985, Lancet (London, England),
C M Petersen, and B K Møller
June 1988, British journal of haematology,
Copied contents to your clipboard!